SGLT2 INHIBITORS VS. GLP1 AGONISTS AS TREATMENTS FOR OSTEOARTHRITIS

被引：0
|
作者：
Jafarzadeh, S. Reza [1 ]
Ma, Kevin [2 ]
Peloquin, Christine E. [1 ]
Felson, David [1 ]
机构：
[1] Boston Univ, Chobanian & Avedisian Sch Med, Boston, MA USA
[2] Goldman Sch Dent Med, Boston, MA USA
来源：
OSTEOARTHRITIS AND CARTILAGE | 2024年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
051
引用
收藏
页码：S41 / S42
页数：2
相关论文
共 50 条
  • [1] Comparative Effectiveness of SGLT2 Inhibitors vs. GLP-1 Agonists
    Poonawalla, Insiya
    Bowe, Andy
    Tindal, Michael
    Meah, Yunus A.
    Schwab, Phil
    [J]. DIABETES, 2020, 69
  • [2] Renal outcomes of SGLT2 inhibitors and GLP1 agonists in clinical practice
    Annemarie B. van der Aart-van der Beek
    Hiddo J. L. Heerspink
    [J]. Nature Reviews Nephrology, 2020, 16 : 433 - 434
  • [3] Renal outcomes of SGLT2 inhibitors and GLP1 agonists in clinical practice
    van der Aart-van der Beek, Annemarie B.
    Heerspink, Hiddo J. L.
    [J]. NATURE REVIEWS NEPHROLOGY, 2020, 16 (08) : 433 - 434
  • [4] COMPARATIVE EFFECTIVENESS OF SGLT2 INHIBITORS VERSUS GLP1 AGONISTS ON PREVENTING POST-TRAUMATIC OSTEOARTHRITIS
    Jafarzadeh, S. Reza
    Peloquin, Christine E.
    Felson, David
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2024, 32 : S595 - S595
  • [5] SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain
    Rolek, Bartosz
    Haber, Mateusz
    Gajewska, Magdalena
    Rogula, Sylwester
    Pietrasik, Arkadiusz
    Gasecka, Aleksandra
    [J]. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (08)
  • [6] SGLT2 inhibitors vs. GLP-1 agonists: Comparative progression of renal disease
    Stevens, Lauren
    Bowe, Andy
    Schwab, Phil
    Tindal, Michael
    Bloomfield, Andrea
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 110 - 110
  • [7] Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protection
    Sridhar, Vikas S.
    Dubrofsky, Lisa
    Boulet, Jacinthe
    Cherney, David Z.
    [J]. JORNAL BRASILEIRO DE NEFROLOGIA, 2020, 42 (04): : 467 - 477
  • [8] DIABETES MEDICATION DECISION SUPPORT IN GIM: INCREASING PRESCRIPTIONS OF SGLT2 INHIBITORS AND GLP1 AGONISTS
    Hilgeman, Brian C.
    Kastner, Mandy
    MacKinney, Theodore
    Maguire, Ann
    Mendez, Carlos
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S413 - S413
  • [9] Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists JACC Focus Seminar
    Wilcox, Tanya
    De Block, Christophe
    Schwartzbard, Arthur Z.
    Newman, Jonathan D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (16) : 1956 - 1974
  • [10] Acceptance of Recommendations for SGLT2 Inhibitors and GLP1 Receptor Agonists in a High-Risk CKD Population
    Weltman, Melanie R.
    Jhamb, Manisha
    Yabes, Jonathan
    Cai, Manqi
    Nolin, Thomas D.
    Abdel-Kader, Khaled
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 865 - 865
12345